Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Some study participants experienced hepatitis B surface antigen loss, considered a functional cure.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
Ending the week with summaries of research from the 2018 Liver Meeting. I cover hepatitis B vaccination, diet and alcoholic liver disease.
A hep C–like virus in the city’s rodents is being used to create the first animal model of the human disease.
The FDA has once again rejected the California-based biotech’s request to approve Heplisav-B.
New treatments for the hepatitis C virus may have cure rates nearing 100 percent, but one global liver disease expert believes the fight again...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.